Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.47 EUR
Change Today -0.03 / -2.00%
Volume 41.9K
ALINS On Other Exchanges
EN Paris
As of 7:11 AM 10/7/15 All times are local (Market data is delayed by at least 15 minutes).

intrasense sas (ALINS) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/20/15 - €3.38
52 Week Low
07/13/15 - €0.70
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for INTRASENSE SAS (ALINS)

Related News

No related news articles were found.

intrasense sas (ALINS) Related Businessweek News

No Related Businessweek News Found

intrasense sas (ALINS) Details

Intrasense SAS designs, develops, and markets medical imaging devices. The company offers Myrian, a software platform that combines and processes medical images to extract information for patient management, and the evaluation of treatment efficacy and oncology drug candidates. It also provides installation, deployment, and contract maintenance services. The company sells its products through a distribution network in approximately 20 countries, including France, Brazil, Russia, India, and China. Intrasense SAS was founded in 2004 and is headquartered in Montpellier, France.

53 Employees
Last Reported Date: 04/30/15
Founded in 2004

intrasense sas (ALINS) Top Compensated Officers

Co-founder, Chief Executive Officer and Direc...
Total Annual Compensation: €138.3K
Co-Founder, Chairman of the Board, Scientific...
Total Annual Compensation: €2.8K
Compensation as of Fiscal Year 2014.

intrasense sas (ALINS) Key Developments

Intrasense SAS Presents at Second French Life Science Days Conference, Jun-17-2015

Intrasense SAS Presents at Second French Life Science Days Conference, Jun-17-2015 . Venue: W Hotel, 541 Lexington Avenue, New York, NY 10022, United States.

Intrasense SAS to Report Fiscal Year 2014 Results on Apr 20, 2015

Intrasense SAS announced that they will report fiscal year 2014 results on Apr 20, 2015

Erasmus University Medical Center Selects Intrasense's Myrian(R) for its Pulmonology Core Lab

Intrasense announced an agreement with LungAnalysis, Erasmus Medical Center's core lab. Erasmus MC has been an Intrasense scientific partner in the field of lung pathologies for several years. With this agreement, it extends the use of Myrian(R) to new advanced research activities, including academic clinical research, industry-sponsored trials and even patient care. The advanced and unique capabilities of its clinical application Myrian(R) XP-Lung allows to measure specific imaging biomarkers. This collaboration validates Intrasense strategy and ability to take advanced technology from clinical research to routine radiology.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALINS:FP €1.47 EUR -0.03

ALINS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALINS.
View Industry Companies

Industry Analysis


Industry Average

Valuation ALINS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.6x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTRASENSE SAS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at